In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

A survey reveals that while awareness of weight loss drugs is rising in India, a majority of citizens prefer non-medical methods due to concerns over side effects and safety. Experts advocate for a ...

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,701.53 today based on a price of $771.99 for LLY at the time of writing.

A Reuters review found that just under half of the claimed spending on the website originated under Joe Biden or represented ...